TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection.
Development of anaemia in inflammatory diseases is cytokine-mediated. Specifically, the levels of tumour necrosis factor-alpha (TNF-alpha), produced by activated macrophages, are correlated with severity of disease and anaemia in infections and chronic disease. In African trypanosomiasis, anaemia develops very early in infection around the time when parasites become detectable in the blood. Since the anaemia persists after the first waves of parasitaemia when low numbers of trypanosomes are circulating in the blood, it is generally assumed that anaemia is not directly induced by a parasite factor, but might be cytokine-mediated, as in other cases of anaemia accompanying inflammation. To clarify the role of TNF-alpha in the development of anaemia, blood parameters of wild type (TNF-alpha+/+), TNF-alpha-null (TNF-alpha-/-) and TNF-alpha-hemizygous (TNF-alpha-/+) trypanotolerant mice were compared during infections with the cattle parasite Trypanosoma congolense. No differences in PCV, erythrocyte numbers or haemoglobin were observed between TNF-alpha-deficient and wild type mice, suggesting that the decrease in erythrocytes was not mediated by TNF-alpha. Erythropoetin (EPO) levels increased during infection and no significant differences in EPO levels were observed between the three mouse strains. In contrast, during an infection with the human pathogen Trypanosoma brucei rhodesiense, the number of red blood cells in TNF-alpha-deficient mice remained significantly higher than in the wild type mice. These data suggest that more than one mechanism promotes the development of anaemia associated with trypanosomiasis.
Naessens
J
J
International livestock Research Institute, Nairobi, Kenya. JNaessens@cigar.org
Kitani
H
H
Nakamura
Y
Y
Yagi
Y
Y
Sekikawa
K
K
Iraqi
F
F
D000740:Anemia / Q000276:immunology* / Q000469:parasitology; D000818:Animals; D006400:Hematocrit; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D016833:Trypanosoma brucei rhodesiense; D014348:Trypanosoma congolense; D014353:Trypanosomiasis, African / Q000276:immunology* / Q000469:parasitology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D014409:Tumor Necrosis Factor-alpha
Cytokine. 2001 Apr 7;14(1):11-8
11298488
Infect Immun. 1999 Jun;67(6):3128-32
10338530
Infect Immun. 2002 Apr;70(4):2210-4
11895989
Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):187-94
12072233
Vet Parasitol. 2003 Feb 13;111(2-3):125-42
12531289
J Clin Invest. 2004 May;113(9):1271-6
15124018
Am J Trop Med Hyg. 1976 May;25(3):401-6
937631
Tropenmed Parasitol. 1978 Mar;29(1):127-33
347651
Parasitology. 1979 Jun;78(3):271-86
481905
J Parasitol. 1980 Feb;66(1):34-7
7365637
Mol Biochem Parasitol. 1981 Feb;2(3-4):177-86
7012615
Res Vet Sci. 1982 Jan;32(1):1-5
7089371
J Comp Pathol. 1982 Jul;92(3):393-401
6183299
Eur J Biochem. 1987 Dec 15;169(3):467-75
3319612
Acta Trop. 1988 Dec;45(4):389-432
2907267
Vet Parasitol. 1989 Jun;31(3-4):199-216
2503920
Proc Natl Acad Sci U S A. 1990 Jan;87(2):801-5
2300563
Acta Trop. 1990 Oct;48(1):37-45
1980802
Parasite Immunol. 1994 Jan;16(1):51-4
7908735
Infect Immun. 1995 Apr;63(4):1563-6
7890423
Exp Parasitol. 1995 May;80(3):407-18
7729476
Br J Rheumatol. 1997 Sep;36(9):950-6
9376990
Lab Invest. 1997 Dec;77(6):647-58
9426403
J Interferon Cytokine Res. 1998 Aug;18(8):555-9
9726435
Immunology. 1998 Aug;94(4):476-80
9767434
Parasite Immunol. 2001 Aug;23(8):445-51
11489168